Deutsche Bank Ag\ Axsome Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 87,758 shares of AXSM stock, worth $7.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,758

Previous 80,203 9.42%

Holding current value

$7.96 Million

Previous $6.46 Million 22.13%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$78.93 - $95.84 $596,316 - $724,071	7,555 Added 9.42%	87,758 $7.89 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $191,968 - $235,140	-2,921 Reduced 3.51%	80,203 $6.46 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $227,044 - $319,478	3,272 Added 4.1%	83,124 $6.63 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $1.14 Million - $1.66 Million	19,806 Added 32.98%	79,852 $6.36 Million
Q3 2023 Nov 09, 2023	BUY	$69.25 - $82.21 $166,684 - $197,879	2,407 Added 4.18%	60,046 $4.2 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $421,720 - $652,327	-7,220 Reduced 11.13%	57,639 $4.14 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $981,827 - $1.26 Million	16,815 Added 35.0%	64,859 $4 Million
Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $104,762 - $209,105	2,623 Added 5.77%	48,044 $3.71 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $32,165 - $62,306	-892 Reduced 1.93%	45,421 $2.03 Million
Q2 2022 Aug 11, 2022	SELL	$21.74 - $46.75 $48,175 - $103,598	-2,216 Reduced 4.57%	46,313 $1.77 Million
Q1 2022 May 13, 2022	SELL	$23.7 - $41.39 $34,981 - $61,091	-1,476 Reduced 2.95%	48,529 $2.01 Million
Q4 2021 Feb 11, 2022	SELL	$30.7 - $43.36 $927,815 - $1.31 Million	-30,222 Reduced 37.67%	50,005 $1.89 Million
Q3 2021 Nov 04, 2021	BUY	$19.91 - $68.26 $677,517 - $2.32 Million	34,029 Added 73.66%	80,227 $2.65 Million
Q2 2021 Aug 11, 2021	SELL	$50.63 - $73.5 $549,436 - $797,622	-10,852 Reduced 19.02%	46,198 $3.12 Million
Q1 2021 May 13, 2021	BUY	$55.91 - $81.44 $216,092 - $314,765	3,865 Added 7.27%	57,050 $3.23 Million
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $429,556 - $560,476	6,478 Added 13.87%	53,185 $4.33 Million
Q3 2020 Nov 12, 2020	BUY	$68.34 - $85.84 $52,348 - $65,753	766 Added 1.67%	46,707 $3.33 Million
Q2 2020 Aug 13, 2020	SELL	$49.87 - $98.69 $49,471 - $97,900	-992 Reduced 2.11%	45,941 $3.78 Million
Q1 2020 May 14, 2020	BUY	$41.2 - $101.31 $428,521 - $1.05 Million	10,401 Added 28.47%	46,933 $2.76 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $486,394 - $3.09 Million	29,108 Added 392.08%	36,532 $3.78 Million
Q3 2019 Nov 14, 2019	SELL	$20.24 - $29.16 $3.43 Million - $4.95 Million	-169,688 Reduced 95.81%	7,424 $148,000
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $2.38 Million - $4.56 Million	177,112 New	177,112 $4.56 Million
Q2 2018 Aug 14, 2018	SELL	$2.15 - $3.6 $718 - $1,202	-334 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.35 - $5.6 $17,155 - $40,880	-7,300 Reduced 95.62%	334 $0
Q4 2017 Feb 14, 2018	BUY	$4.45 - $6.2 $33,820 - $47,120	7,600 Added 22352.94%	7,634 $42,000
Q3 2017 Nov 14, 2017	BUY	$4.65 - $6.1 $158 - $207	34	34 $0

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account